Healthcare - Biotechnology - NASDAQ - US
$ 48.76
-4.58 %
$ 2.56 B
Market Cap
-41.68
P/E
BALANCE SHEET
380 M
ASSETS
36.1 M
LIABILITIES
344 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Janux Therapeutics, Inc.
| Current Assets | 349 M |
| Cash & Short-Term Investments | 344 M |
| Receivables | 0 |
| Other Current Assets | 5.21 M |
| Non-Current Assets | 31.2 M |
| Long-Term Investments | 0 |
| PP&E | 27.8 M |
| Other Non-Current Assets | 3.32 M |
| Current Liabilities | 13 M |
| Accounts Payable | 2.42 M |
| Short-Term Debt | 3.03 M |
| Other Current Liabilities | 7.58 M |
| Non-Current Liabilities | 23 M |
| Long-Term Debt | 46 M |
| Other Non-Current Liabilities | -23 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 19.2 | 51.4 | 35.6 | 7.8 | 0.7 |
| Short Term Investments | 324.8 | 275.6 | 339.4 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 8.0 | 0 |
| Inventory | 0 | (0.7) | (0.2) | 0 | 0 |
| Other Current Assets | 5.2 | 5.4 | 4.1 | 0.5 | 0 |
| Total Current Assets | 349.2 | 332.4 | 377.0 | 16.1 | 0.7 |
| PP&E | 27.8 | 29.4 | 1.6 | 0.2 | 21 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.8 | 0.8 | 0 | 0 |
| Other Long Term Assets | 3.3 | 1.4 | 0.4 | (0.2) | 21 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 380.4 | 364.0 | 379.8 | 16.2 | 0.7 |
| LIABILITIES | |||||
| Accounts Payable | 2.4 | 2.2 | 2.5 | 0.4 | 0.3 |
| Short Term Debt | 3.0 | 1.5 | 0.4 | 0 | 4.0 |
| Other Current Liabilities | 5.9 | 7.4 | 4.8 | 0.8 | 0.4 |
| Total Current Liabilities | 13.0 | 16.5 | 12.8 | 3.2 | 4.6 |
| Long Term Debt | 46.0 | 49.1 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | (2.2) | 0 | 0 | 0 |
| Other Liabilities | (23.0) | (24.5) | 0 | 21.6 | 0 |
| Total Liabilities | 36.1 | 43.3 | 13.5 | 30.9 | 8.6 |
| EQUITY | |||||
| Common Stock | 46 K | 42 K | 41 K | 1 K | 1 K |
| Retained Earnings | (168.8) | (110.5) | (47.4) | (14.7) | (8.0) |
| Other Accumulative Comprehensive Income/Loss | 0.7 | (1.5) | (0.3) | (21.6) | (4.0) |
| Total Equity | 344.3 | 320.7 | 366.3 | (14.6) | (7.9) |
| Total Liabilities and Equity | 380.4 | 364.0 | 379.8 | 16.2 | 0.7 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 44.0 | 41.5 | 41.2 | 41.6 | 41.6 |